BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 34774738)

  • 1. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses.
    Aleebrahim-Dehkordi E; Molavi B; Mokhtari M; Deravi N; Fathi M; Fazel T; Mohebalizadeh M; Koochaki P; Shobeiri P; Hasanpour-Dehkordi A
    Transpl Immunol; 2022 Feb; 70():101495. PubMed ID: 34774738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
    Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():593595. PubMed ID: 33995342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of and Public Health Emergency Responses to COVID-19 and H1N1 Outbreaks: A Case-Comparison Study.
    Wang Q; Zhang T; Zhu H; Wang Y; Liu X; Bai G; Dai R; Zhou P; Luo L
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics.
    da Costa VG; Saivish MV; Santos DER; de Lima Silva RF; Moreli ML
    J Infect Public Health; 2020 Dec; 13(12):1797-1804. PubMed ID: 33121906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
    Nittayananta W; Lerdsamran H; Chutiwitoonchai N; Promsong A; Srichana T; Netsomboon K; Prasertsopon J; Kerdto J
    Virol J; 2024 Jan; 21(1):26. PubMed ID: 38263162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Infection in Ferrets with SARS-CoV-2 Infection History.
    Vilas Boas de Melo C; Peters F; van Dijken H; Lenz S; van de Ven K; Wijsman L; Gomersbach A; Schouten T; van Kasteren PB; van den Brand J; de Jonge J
    Microbiol Spectr; 2022 Dec; 10(6):e0138622. PubMed ID: 36301107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.
    Stölting H; Baillon L; Frise R; Bonner K; Hewitt RJ; Molyneaux PL; Gore ML; ; Barclay WS; Saglani S; Lloyd CM
    Mucosal Immunol; 2022 May; 15(5):952-963. PubMed ID: 35840680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of yogurt containing probiotics on respiratory virus infections: Influenza H1N1 and SARS-CoV-2.
    Jeon HY; Kim KS; Kim S
    J Dairy Sci; 2023 Mar; 106(3):1549-1561. PubMed ID: 36631322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus.
    Khatri M; Dwivedi V; Krakowka S; Manickam C; Ali A; Wang L; Qin Z; Renukaradhya GJ; Lee CW
    J Virol; 2010 Nov; 84(21):11210-8. PubMed ID: 20719941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome and a pulmonary sarcoidosis.
    Baala L; Benzekri-Lefevre D; Bret L; Guillaume C; Courtellemont L; El Khalil A; Guery T; Iquel S; Perche O; Khadre K; Brungs T; Decker J; Francia T; Bois J; Delamare B; Guinard J; Got L; Briault S; Boulain T; Legac E
    F1000Res; 2020; 9():1482. PubMed ID: 35528205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Ophthalmologist's Insight Into The Viral Pandemics.
    Dhiman R; Rakheja V; Saxena R
    J Optom; 2022; 15(1):35-43. PubMed ID: 33422421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic.
    Jhaveri R
    Clin Ther; 2020 May; 42(5):736-740. PubMed ID: 32331805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
    Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
    PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
    Sunagawa S; Iha Y; Kinjo T; Nakamura K; Fujita J
    Respir Investig; 2021 Jan; 59(1):149-152. PubMed ID: 33246913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
    Kulasinghe A; Tan CW; Ribeiro Dos Santos Miggiolaro AF; Monkman J; SadeghiRad H; Bhuva DD; Motta Junior JDS; Busatta Vaz de Paula C; Nagashima S; Baena CP; Souza-Fonseca-Guimaraes P; de Noronha L; McCulloch T; Rossi GR; Cooper C; Tang B; Short KR; Davis MJ; Souza-Fonseca-Guimaraes F; Belz GT; O'Byrne K
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.